According to its SEC filing dated February 17, 2026, Parkman Healthcare Partners established a new position in Masimo by buying 200,000 shares. The new stake brought the fund’s quarter-end position in ...

Now, it’s worth noting Stock Advisor’s total average return is 930 % — a market-crushing outperformance compared to 187% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...

It’s their third win in a row and gives them a fighting chance of a top half finish and a place in next season’s Champions Cup in addition to reaching the league quarter-finals ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Connacht delivered a much-needed win over the Scarlets to give them further momentum in their quest for a top-eight place in the URC. Their fifth win of the season came at Dexcom Stadium, where ...

BTIG analysts continue to expect growth from Dexcom (Nasdaq:DXCM) after meeting with the company's senior investor relations (IR) officials.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

In the preceding three months, 12 analysts have released ratings for DexCom (NASDAQ:DXCM), presenting a wide array of ...

MiniMed (MMED) shares drop 4.8% in Nasdaq debut, opening at $19.05 after raising $560M in IPO. Medtronic (MDT) retains 90% stake in diabetes device spinoff.

Dexcom will stop producing G6 CGM sensors July 1, 2026, urging patients to switch to the smaller, more accurate G7 model.

Without a specific news headline driving the move, DexCom (DXCM) sits at a recent close of US$70.69, leaving investors weighing its continuous glucose monitoring business against recent share price ...

DexCom has underperformed the Nasdaq Composite over the past year, yet analysts remain highly optimistic about the stock’s ...